TRAA Stock Overview
Provides business and finance advisory services for small and medium sized companies.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Traack Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.025 |
| 52 Week High | US$0.17 |
| 52 Week Low | US$0.0061 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -39.02% |
| 33 Year Change | -89.58% |
| 5 Year Change | -37.50% |
| Change since IPO | -99.75% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| TRAA | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | 2.1% |
| 1Y | -39.0% | 16.5% | 20.5% |
Return vs Industry: TRAA underperformed the US Pharmaceuticals industry which returned 16.5% over the past year.
Return vs Market: TRAA underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| TRAA volatility | |
|---|---|
| TRAA Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TRAA's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine TRAA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Brett Pojunis | www.nvest.us |
Traack Technologies Inc. provides business and finance advisory services for small and medium sized companies. The company focuses on creating business plans and general management consulting. Its advisory services include corporate formation and structure, business plan creation and development, business planning and expansion, strategic planning, mergers and acquisition, and business advisory services.
Traack Technologies Inc. Fundamentals Summary
| TRAA fundamental statistics | |
|---|---|
| Market cap | US$441.00k |
| Earnings (TTM) | -US$513.88k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs TRAA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRAA income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$513.88k |
| Earnings | -US$513.88k |
Last Reported Earnings
Jan 31, 2016
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did TRAA perform over the long term?
See historical performance and comparison